Page last updated: 2024-11-07

prednisone and Facies

prednisone has been researched along with Facies in 2 studies

Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.

Facies: The appearance of the face that is often characteristic of a disease or pathological condition, as the elfin facies of WILLIAMS SYNDROME or the mongoloid facies of DOWN SYNDROME. (Random House Unabridged Dictionary, 2d ed)

Research Excerpts

ExcerptRelevanceReference
"Leonine facies is rare and corresponds to the morphologic manifestation of diffuse dermal infiltration of the face."1.37Sezary syndrome presenting with leonine facies and treated with low-dose subcutaneous alemtuzumab. ( Alves, R; Lima, M; Lobo, I; Oliveira, A; Selores, M, 2011)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Picco, P1
Naselli, A1
Pala, G1
Marsciani, A1
Buoncompagni, A1
Martini, A1
Oliveira, A1
Lobo, I1
Alves, R1
Lima, M1
Selores, M1

Other Studies

2 other studies available for prednisone and Facies

ArticleYear
Recurrent pericarditis in Myhre syndrome.
    American journal of medical genetics. Part A, 2013, Volume: 161A, Issue:5

    Topics: Child; Cryptorchidism; Facies; Growth Disorders; Hand Deformities, Congenital; Humans; Hypertrophy;

2013
Sezary syndrome presenting with leonine facies and treated with low-dose subcutaneous alemtuzumab.
    Dermatology online journal, 2011, Nov-15, Volume: 17, Issue:11

    Topics: Alemtuzumab; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Biop

2011